Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines.
暂无分享,去创建一个
D. Chopin | M. Jaurand | F. Vacherot | J. Riffaud | M. Bolla | Sandra Huguenin | L. Kheuang | J. Fleury-Feith | J. Fleury‐Feith